Development Concept
Lytica™ Biofilm Intervention Concept
An enzyme-and-phage approach to oral biofilm, in development.
Lytica is a development concept exploring a staged enzyme-and-phage approach to oral biofilm. Formulation, delivery, safety, clinical benefit and intended use still require evaluation. This is not a treatment protocol.
Proposed Direction
Evaluate biofilm intervention as a defined, testable formulation.
Before Clinical Use
Establish safety, performance, appropriate evidence and intended-use requirements.
An expression of interest, not a reservation or promise of access.
By requesting updates, you ask Fasolati to contact you about this development. Your email and product interest are sent through HubSpot. We confirm acceptance only after the service responds successfully. Please do not send health records. How this website handles information.